GRASSILLI EMANUELA

Ilari, A., Cogliati, V., Sherif, N., Grassilli, E., Ramazzotti, D., Cordani, N., et al. (2024). Differential Expression of NOTCH-1 and Its Molecular Targets in Response to Metronomic Followed by Conventional Therapy in a Patient with Advanced Triple-Negative Breast Cancer. BIOMEDICINES, 12(2) [10.3390/biomedicines12020272]. Detail

Grassilli, E., Cerrito, M. (2023). "Ironing out" fasting-induced persister cancer cells to render chemotherapy effective: is this the solution?. EBIOMEDICINE, 90(April 2023) [10.1016/j.ebiom.2023.104542]. Detail

Betzler, A., Strobel, H., Abou Kors, T., Ezić, J., Lesakova, K., Pscheid, R., et al. (2023). BTK Isoforms p80 and p65 Are Expressed in Head and Neck Squamous Cell Carcinoma (HNSCC) and Involved in Tumor Progression. CANCERS, 15(1) [10.3390/cancers15010310]. Detail

Scagliotti, A., Capizzi, L., Cazzaniga, M., Ilari, A., De Giorgi, M., Cordani, N., et al. (2022). Co-targeting triple-negative breast cancer cells and endothelial cells by metronomic chemotherapy inhibits cell regrowth and migration via downregulation of the FAK/VEGFR2/VEGF axis and autophagy/apoptosis activation. FRONTIERS IN ONCOLOGY, 12 [10.3389/fonc.2022.998274]. Detail

Grassilli, E., Cerrito, M. (2022). Emerging actionable targets to treat therapy-resistant colorectal cancers. CANCER DRUG RESISTANCE, 5(1), 36-63 [10.20517/cdr.2021.96]. Detail